Difference between revisions of "Template:Antithrombotics"

From blackwiki
Jump to navigation Jump to search
blackwiki>NSH002
(tidy up)
Line 1: Line 1:
 
{{Navbox
 
{{Navbox
| name = Antithrombotics
+
| name = Antithrombotics
| title = [[Antithrombotic]]s ([[thrombolytic drug|thrombolytics]], [[anticoagulant]]s and [[antiplatelet drug]]s) ([[ATC code B01|B01]])
+
| title = [[Antithrombotic]]s ([[Thrombolytic drug|thrombolytics]], [[anticoagulant]]s and [[antiplatelet drug]]s) ([[ATC code B01|B01]])
| state = {{{state|autocollapse}}}
+
| state = {{{state<includeonly>|autocollapse</includeonly>}}}
| bodyclass = hlist
+
| bodyclass = hlist
  
| group1 = [[Antiplatelet drug]]s
+
| group1 = [[Antiplatelet drug]]s
| list1 = {{Navbox subgroup
+
| list1 = {{Navbox|child
  
| group1 = [[Glycoprotein IIb/IIIa inhibitors]]
+
  | group1 = [[Glycoprotein IIb/IIIa inhibitors]]
| list1 =
+
  | list1 =
 
* [[Abciximab]]
 
* [[Abciximab]]
 
* [[Eptifibatide]]
 
* [[Eptifibatide]]
 
* [[Tirofiban]]
 
* [[Tirofiban]]
*[[Roxifiban]]
+
* [[Roxifiban]]
*[[Orbofiban]]
+
* [[Orbofiban]]
  
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
+
  | group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
| list2 =
+
  | list2 =
 
* [[Thienopyridine]]s
 
* [[Thienopyridine]]s
 
** [[Clopidogrel]]
 
** [[Clopidogrel]]
Line 27: Line 27:
 
** [[Ticagrelor]]
 
** [[Ticagrelor]]
  
| group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
+
  | group3 = [[Prostaglandin analogue]] ([[Prostacyclin|PGI2]])
| list3 =
+
  | list3 =
 
* [[Beraprost]]
 
* [[Beraprost]]
 
* [[Iloprost]]
 
* [[Iloprost]]
Line 34: Line 34:
 
* [[Treprostinil]]
 
* [[Treprostinil]]
  
| group4 = [[Mechanism of action of aspirin|COX inhibitors]]
+
  | group4 = [[Mechanism of action of aspirin|COX inhibitors]]
| list4 =
+
  | list4 =
 
* [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>
 
* [[Aspirin|Acetylsalicylic acid/Aspirin]]<sup>#</sup>
 
* [[Aloxiprin]]
 
* [[Aloxiprin]]
Line 42: Line 42:
 
* [[Triflusal]]
 
* [[Triflusal]]
  
| group5 = [[Thromboxane inhibitors]]
+
  | group5 = [[Thromboxane inhibitors]]
| list5 =
+
  | list5 =
 
* [[Thromboxane synthase inhibitors]]
 
* [[Thromboxane synthase inhibitors]]
 
** [[Dipyridamole]] ([[Acetylsalicylic acid/dipyridamole|+Aspirin]])
 
** [[Dipyridamole]] ([[Acetylsalicylic acid/dipyridamole|+Aspirin]])
Line 50: Line 50:
 
** [[Terutroban]]<sup>†</sup>
 
** [[Terutroban]]<sup>†</sup>
  
| group6 = [[Phosphodiesterase inhibitor]]s
+
  | group6 = [[Phosphodiesterase inhibitor]]s
| list6 =
+
  | list6 =
 
* [[Cilostazol]]
 
* [[Cilostazol]]
 
* [[Dipyridamole]]
 
* [[Dipyridamole]]
 
* [[Triflusal]]
 
* [[Triflusal]]
  
| group7 = Other
+
  | group7 = Other
| list7 =
+
  | list7 =
 
* [[Cloricromen]]
 
* [[Cloricromen]]
 
* [[Ditazole]]
 
* [[Ditazole]]
 
* [[Vorapaxar]]
 
* [[Vorapaxar]]
}}
 
  
| group2 = [[Anticoagulant]]s
+
  }}
| list2 = {{Navbox subgroup
 
  
  | group2 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
+
| group2 = [[Anticoagulant]]s
  | list2 =
+
| list2 = {{Navbox|child
 +
  | evenodd = swap
 +
 
 +
  | group1 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
 +
  | list1 =
 
* [[Coumarin]]s: [[Acenocoumarol]]
 
* [[Coumarin]]s: [[Acenocoumarol]]
 
* [[Coumatetralyl]]
 
* [[Coumatetralyl]]
Line 79: Line 81:
 
* Other: [[Tioclomarol]]
 
* Other: [[Tioclomarol]]
  
| group3 = [[Factor Xa]] inhibitors<br />(with some II inhibition)
+
  | group2 = [[Factor Xa]] inhibitors<br />(with some II inhibition)
| list3 = {{Navbox subgroup
+
  | list2 = {{Navbox|child
 
 
  
| group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
+
    | group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
| list1 =
+
    | list1 =
 
* [[Low molecular weight heparin]]
 
* [[Low molecular weight heparin]]
 
** [[Bemiparin sodium|Bemiparin]]
 
** [[Bemiparin sodium|Bemiparin]]
Line 102: Line 103:
 
** [[Sulodexide]]
 
** [[Sulodexide]]
  
| group2 = [[Direct Xa inhibitor]]s
+
    | group2 = [[Direct Xa inhibitor]]s
| list2 =
+
    | list2 =
 
* Xabans
 
* Xabans
 
** [[Apixaban]]
 
** [[Apixaban]]
Line 111: Line 112:
 
** [[Otamixaban]]<sup>§</sup>
 
** [[Otamixaban]]<sup>§</sup>
 
** [[Rivaroxaban]]
 
** [[Rivaroxaban]]
}}
 
  
| group5 = [[Direct thrombin inhibitor|Direct thrombin (IIa) inhibitor]]s
+
  }}
| list5 =
+
 
* [[Direct_thrombin_inhibitor#Bivalent|Bivalent]]: [[Hirudin]]
+
<!-- group3 omitted to preserve alternating striping -->
 +
 
 +
  | group4 = [[Direct thrombin inhibitor|Direct thrombin (IIa) inhibitor]]s
 +
  | list4 =
 +
* [[Direct thrombin inhibitor#Bivalent|Bivalent]]: [[Hirudin]]
 
** [[Bivalirudin]]
 
** [[Bivalirudin]]
 
** [[Desirudin]]
 
** [[Desirudin]]
 
** [[Lepirudin]]
 
** [[Lepirudin]]
* [[Direct_thrombin_inhibitor#Univalent|Univalent]]: [[Argatroban]]
+
* [[Direct thrombin inhibitor#Univalent|Univalent]]: [[Argatroban]]
 
* [[Dabigatran]]
 
* [[Dabigatran]]
 
* [[Melagatran]]<sup>‡</sup>
 
* [[Melagatran]]<sup>‡</sup>
 
* [[Ximelagatran]]<sup>‡</sup>
 
* [[Ximelagatran]]<sup>‡</sup>
  
| group6 = Other
+
  | group5 = Other
| list6 =
+
  | list5 =
 
* [[Antithrombin|Antithrombin III]]
 
* [[Antithrombin|Antithrombin III]]
 
* [[Defibrotide]]
 
* [[Defibrotide]]
Line 132: Line 136:
 
* [[Ramatroban]]
 
* [[Ramatroban]]
 
* [[REG1<!--instantly reversible aptamer-based direct FIXa inhibitor in IIb trials -->]]
 
* [[REG1<!--instantly reversible aptamer-based direct FIXa inhibitor in IIb trials -->]]
}}
 
  
| group3 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
+
}}
| list3 =
+
 
* [[Plasminogen activator]]s: [[recombinant tissue plasminogen activators|r-tPA]]
+
| group3 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
 +
| list3 =
 +
* [[Plasminogen activator]]s: [[Recombinant tissue plasminogen activators|r-tPA]]
 
** [[Tissue plasminogen activator|Alteplase]]
 
** [[Tissue plasminogen activator|Alteplase]]
 
** [[Reteplase]]
 
** [[Reteplase]]
Line 146: Line 151:
 
* [[Monteplase]]
 
* [[Monteplase]]
 
* [[Streptokinase]]<sup>#</sup>
 
* [[Streptokinase]]<sup>#</sup>
*Other [[serine endopeptidase]]s: [[Ancrod]]
+
* Other [[serine endopeptidase]]s: [[Ancrod]]
 
* [[Brinase]]
 
* [[Brinase]]
 
* [[Fibrinolysin]]
 
* [[Fibrinolysin]]
  
| group4 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
+
| group4 = [[Anticoagulant#Anticoagulants outside the body|Non-medicinal]]
| list4 =
+
| list4 =
 
* [[Citrate]]
 
* [[Citrate]]
 
* [[Ethylenediaminetetraacetic acid|EDTA]]
 
* [[Ethylenediaminetetraacetic acid|EDTA]]
 
* [[Oxalate]]
 
* [[Oxalate]]
  
| belowstyle = background: transparent; padding: 0px;
+
| belowstyle = background: transparent; padding: 0px;
| below = {{PharmNavFootnote}} {{Myeloid navs}}
+
| below = {{PharmNavFootnote}} {{Myeloid navs}}
  
 
}}<noinclude>
 
}}<noinclude>
 
{{collapsible option}}
 
{{collapsible option}}
[[Category:Antithrombotic agents]]
+
[[Category:Drug templates by ATC]]
[[Category:Drug_templates by ATC]]
 
 
 
 
</noinclude>
 
</noinclude>

Revision as of 10:23, 3 June 2015

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Antithrombotics|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Antithrombotics|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Antithrombotics|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.